Study of BC3195 Monotherapy in Patients With Advanced Solid Tumors

NCT05957471 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Solid Tumors

Interventions

DRUG: Drug: BC3195 for Injection

Sponsor

Biocity Biopharmaceutics Co., Ltd.